GENB - CIK 0002100782
As of 2026-06-11, Generate Biomedicines, Inc. (GENB) has a market capitalization of $1.69 B, making it the #2227 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-06-11 | $1.69 B |
| 2026-06-10 | $1.69 B |
| 2026-05-29 | $1.70 B |
| 2026-05-28 | $1.68 B |
| 2026-05-26 | $1.74 B |
| 2026-05-25 | $1.86 B |
| 2026-05-24 | $1.86 B |
| 2026-05-22 | $1.86 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
As of 2026-06-11, Generate Biomedicines, Inc. (GENB) has a market capitalization of $1.69 B, making it the #2227 most valuable US-listed company.
Generate Biomedicines, Inc. is the #2227 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.